Lenced 10mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat thyroid cancer, liver cancer (HCC), and kidney cancer (RCC).
| Composition | Lenvatinib |
| Manufacturer | Zydus Cadila |
| Packing | 10 Capsule(s) In A Strip |
| Prescribed For | Thyroid cancer, Liver cancer, and Kidney cancer |
| Expiry | December 2027 |
Lenalid 25mg Capsule contains Lenalidomide, a prescription medicine used to treat certain types of blood cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Composition | Lenalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Expiry | December 2027 |
Lenakast 25 mg Capsule is an oral anticancer medication containing Lenalidomide, primarily used in the treatment of multiple myeloma, myelodysplastic syndromes, and certain types of lymphomas.
| Composition | Lenalidomide |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Expiry | December 2027 |
Tenolam E Tablet is a combination of three HIV medications: efavirenz (600 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg), and it is used to treat HIV-1 infection in adults and teenagers.
| Composition | Efavirenz 600mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300 mg |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Xapavir 50mg Tablet contains Dolutegravir, an antiretroviral medication used in the treatment of HIV-1 infection. It belongs to the class of drugs known as integrase strand transfer inhibitors (INSTIs).
| Composition | Dolutegravir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Bracanat 150 mg Tablet is an oral anticancer medicine containing Olaparib, used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. It works by blocking cancer cell DNA repair, helping slow disease progression.
| Composition | Olaparib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | Ovarian and Breast Cancer |
| Expiry | December 2027 |
Olabir 150 mg Tablet is an oral anticancer medication containing olaparib, a PARP inhibitor used to treat cancers associated with BRCA gene mutations. It is commonly prescribed for ovarian, breast, pancreatic, and prostate cancers, helping to slow cancer progression and improve survival in advanced stages.
| Composition | Olaparib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | Ovarian and Breast Cancer |
| Expiry | December 2027 |
Hepcvel 400mg/100mg Tablet is a combination of Sofosbuvir 400mg and Velpatasvir 100mg used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
| Manufacturer | Cipla Ltd |
| Packing | 28 Tablets in 1 Strip |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Hertab 250mg Tablet contains Lapatinib, a targeted cancer therapy used in the treatment of HER2-positive breast cancer. It works by blocking specific proteins (HER2 and EGFR) that promote the growth of cancer cells, thereby slowing or stopping tumor progression.
| Composition | Lapatinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Tablets in a Bottle |
| Prescribed For | Breast Cancers |
| Expiry | December 2027 |
Ibrunat 140mg Capsule contains Ibrutinib, a targeted cancer therapy used to treat certain blood cancers such as Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM).
| Composition | Ibrutinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsule in a Bottle |
| Prescribed For | Blood Cancers |
| Expiry | December 2027 |
Imat 400mg Tablet contains Imatinib, a targeted chemotherapy medicine used to treat certain types of cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
| Composition | Imatinib |
| Manufacturer | Zydus Healthcare Limited |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumors |
| Expiry | December 2027 |
Imatikast 400mg Tablet contains Imatinib, a targeted cancer therapy used to treat certain types of cancers such as Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs).
| Composition | Imatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Gastrointestinal Stromal Tumors |
| Expiry | December 2027 |
Inbec Tablet is a fixed-dose combination of Abacavir (600mg), Dolutegravir (50mg), and Lamivudine (300mg), used in the treatment of HIV-1 infection in adults and adolescents.
| Composition | Abacavir (600mg) + Dolutegravir (50mg) + Lamivudine (300mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Strip |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Indenza 40mg Capsule is an anti-cancer medication that contains Enzalutamide, used primarily in the treatment of prostate cancer.
| Composition | Enzalutamide 40mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Capsules in 1 Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Invista 100mg Tablet contains Dasatinib, a targeted cancer medication used in the treatment of certain types of blood cancers, including Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) that are Philadelphia chromosome-positive.
| Composition | Dasatinib |
| Manufacturer | Dr Reddy’s Laboratories Ltd |
| Packing | 10 Tablet in 1 Strip |
| Prescribed For | Chronic Myeloid Leukemia |
| Expiry | December 2027 |
Iversuvac 12 mg Tablet contains Ivermectin, a widely used antiparasitic medicine effective against various parasitic infections such as intestinal strongyloidiasis, onchocerciasis (river blindness), scabies, and lice infestations.
| Composition | Ivermectin |
| Manufacturer | Medsuvac |
| Packing | 10 Tablets |
| Prescribed For | Parasitic Infections |
| Expiry | December 2027 |
Ledifos Tablet is a combination of Ledipasvir (90mg) and Sofosbuvir (400mg), used for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Ledipasvir (90mg) and Sofosbuvir (400mg) |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 28 Tablets in a Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Lenangio 25mg Capsule contains Lenalidomide, a medicine used to treat certain types of blood cancers such as multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Composition | Lenalidomide |
| Manufacturer | Dr Reddy’s Laboratories Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Multiple Myeloma, Myelodysplastic Syndrome and Mantle Cell Lymphoma |
| Expiry | December 2027 |
Lenshil 4mg Capsule contains Lenvatinib, a targeted cancer medicine used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lentris 10mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat advanced stages of thyroid cancer, liver cancer (hepatocellular carcinoma), and kidney cancer (renal cell carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvakast 10mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of advanced thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules in a Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvat 10mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules in a Bottle |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvatol 10mg Capsule contains Lenvatinib, a targeted anti-cancer medicine used for treating certain types of advanced or metastatic cancers including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Cipla Ltd |
| Packing | 10 Capsules in a Bottle |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvenib 4mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat advanced thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Leu Kinib 70mg contains Dasatinib, a targeted therapy used for treating certain types of blood cancers such as Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Sayre Therapeutics Pvt Ltd |
| Packing | 60 Tablets in 1 bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Luprodex Depot Injection contains Leuprolide Acetate, a synthetic hormone used to manage hormone-related conditions. It is available in strengths of 3.75 mg, 11.25 mg, and 22.5 mg, and works as a gonadotropin-releasing hormone (GnRH) agonist.
| Composition | Leuprolide |
| Manufacturer | Bharath Serum & Vaccines Ltd |
| Packing | 1 Vial of 2ml |
| Prescribed For | Prostate Cancer, Endometriosis, Uterine Fibroids, Female infertility |
| Expiry | December 2027 |
Micafung Plus 100mg Injection contains Micafungin, an antifungal medication used to treat serious fungal infections such as candidemia, esophageal candidiasis, and invasive Candida infections.
| Composition | Micafungin |
| Manufacturer | Gufic Bioscience Ltd |
| Packing | 1.0 Injection in 1 vial |
| Prescribed For | Fungal Infections |
| Expiry | December 2027 |
Mitomycin Injection 40mg is an anti-cancer (chemotherapy) medication used to treat various types of cancers, including stomach cancer, pancreatic cancer, breast cancer, bladder cancer, and others.
| Manufacturer | Biochem Pharmaceutical Industries |
| Packing | 1.0 Injection in 1 vial |
| Prescribed For | Stomach Cancer, Pancreatic Cancer, Breast Cancer and Bladder Cancer |
| Expiry | December 2027 |
Morovir 200mg Capsules contain Molnupiravir, an oral antiviral medication used for the treatment of mild to moderate COVID-19 in adults at risk of developing severe illness.
| Composition | Molnupiravir |
| Manufacturer | Bruck Pharma Pvt. Ltd |
| Packing | 40 Capsules |
| Prescribed For | (COVID-19) |
| Expiry | December 2027 |
Moluzaq 200mg contains Molnupiravir, an oral antiviral medicine developed to treat mild to moderate COVID-19 in adults at risk of developing severe illness.
| Composition | Molnupiravir |
| Manufacturer | Astraea Life Sciences Pvt Ltd |
| Packing | 10 Capsules in 1 Strip |
| Prescribed For | (COVID-19) |
| Expiry | December 2027 |
Mycamine 100mg Injection contains Micafungin, an antifungal medicine used to treat and prevent serious fungal infections.
| Composition | Micafungin |
| Manufacturer | Astellas Pharma Inc |
| Packing | 1.0 Injection in 1 vial |
| Prescribed For | Fungal Infections |
| Expiry | December 2027 |
Myhep All Tablet is a fixed-dose combination of Velpatasvir 100mg and Sofosbuvir 400mg used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Natdac 60mg Tablet contains Daclatasvir, a direct-acting antiviral medication used in combination with other drugs for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Daclatasvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Nextki 100mg Tablet contains Dasatinib, a targeted cancer therapy used to treat certain blood cancers, specifically Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Nitib 140mg Capsule contains Ibrutinib, a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia.
| Composition | Ibrutinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Nitnib 50mg contains Sunitinib Malate, a targeted cancer therapy used to treat certain types of cancers including advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Zydus Cadila |
| Packing | 7 Capsules in Strip |
| Prescribed For | Kidney Cancer, Gastrointestinal Stromal Tumors & Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Nuparp 300mg Tablet contains Rucaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of certain types of cancer, including advanced ovarian and prostate cancers associated with BRCA mutations.
| Composition | Rucaparib |
| Manufacturer | Zydus Cadila |
| Packing | 60 Tablets in a Bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Obnyx 40mg contains Enzalutamide, an oral anti-cancer medication used to treat metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) in adult men.
| Composition | Enzalutamide |
| Manufacturer | Zydus Cadila |
| Packing | 4 Capsules in Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Pazinib 400mg contains Pazopanib, and is used to treat advanced kidney cancer (renal cell carcinoma) and certain types of soft tissue sarcoma in adults who have received prior chemotherapy.
| Composition | Pazopanib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Kidney Cancer |
| Expiry | December 2027 |
Pemetero 500 mg Injection contains Pemetrexed, an anti-cancer medication used primarily to treat non-small cell lung cancer(NSCLC) and malignant pleural mesothelioma.
| Composition | Pemetrexed |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 1 Injection in 1 Vial |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Picasa contains Posaconazole, an antifungal medication used to treat and prevent serious fungal infections, especially in people with weakened immune systems, such as those undergoing chemotherapy or stem cell transplants.
| Composition | Posaconazole |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 105 ml in 1 bottle |
| Prescribed For | Severe Fungal Infections |
| Expiry | December 2027 |
Piclib 125 mg Capsule contains Palbociclib, a targeted therapy used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer.
| Composition | Palbociclib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 21 Capsules in 1 Bottle |
| Prescribed For | Metastatic Breast Cancer |
| Expiry | December 2027 |
Pirfenex 200 mg tablet contains Pirfenidone, a medication used to treat Idiopathic Pulmonary Fibrosis (IPF) – a progressive lung disease that causes scarring (fibrosis) of the lung tissue.
| Composition | Pirfenidone |
| Manufacturer | Cipla Ltd |
| Packing | 15 Tablets in 1 Strip |
| Prescribed For | Idiopathic Pulmonary Fibrosis |
| Expiry | December 2027 |
Pomalid 2mg Capsule contains Pomalidomide, an immunomodulatory drug used in the treatment of multiple myeloma (a type of blood cancer), especially in patients who have not responded to other therapies such as lenalidomide and bortezomib.
| Composition | Pomalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 21 Capsules in 1 Bottle |
| Prescribed For | Multiple Myeloma |
| Expiry | December 2027 |
Prazivac 600mg contains Praziquantel, an antiparasitic medication used to treat schistosomiasis and liver fluke infections, as well as tapeworm infestations such as neurocysticercosis.
| Composition | Praziquantel |
| Manufacturer | Medsuvac Lifesciences Private Limited |
| Packing | 4 Tablets in 1 Strip |
| Prescribed For | Worm Infection and Schistosoma Infection |
| Expiry | December 2027 |
Puretrig AQ 5000IU Injection contains Human Chorionic Gonadotropin (hCG), a hormone used primarily in the treatment of infertility in both men and women.
| Composition | Human Chorionic Gonadotropin (hCG) (5000IU) |
| Manufacturer | Gufic Bioscience Ltd |
| Packing | 1 Injection in 1 Vial |
| Prescribed For | Female Infertility |
| Expiry | December 2027 |
Raltegravir 400mg Tablet is used as part of antiretroviral therapy (ART) to treat HIV-1 infection. It helps lower the viral load and improve immune system function.
| Composition | Raltegravir 400mg |
| Manufacturer | Globela Pharma Pvt Ltd |
| Packing | 60 Tablets in 1 Strip |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Ramiven 150mg Tablet contains Abemaciclib, a cancer medicine used in the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer.
| Composition | Abemaciclib 150mg |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Packing | 7 Tablets in 1 Strip |
| Prescribed For | Metastatic Breast Cancer |
| Expiry | December 2027 |
Rebopag Tablet contains eltrombopag and is used to treat low platelet counts in conditions like chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and thrombocytopenia in hepatitis C patients.
| Composition | Eltrombopag |
| Manufacturer | MSN Laboratories (India) |
| Packing | 7 Tablets in 1 Strip |
| Prescribed For | Chronic Idiopathic Thrombocytopenia |
| Expiry | December 2027 |
Regonat 40 mg Tablet contains Regorafenib, a targeted chemotherapy medicine used to treat certain types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Colorectal Cancer, Liver Cancer and GIST |
| Expiry | December 2027 |
Relidomide 25 capsules contains Lenalidomide 25mg, an immunomodulatory medication primarily used in the treatment of certain blood cancers such as multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma.
| Composition | Lenalidomide 25mg |
| Manufacturer | Reliance Life Sciences |
| Packing | 21 Capsules in 1 Bottle |
| Prescribed For | Multiple Myeloma |
| Expiry | December 2027 |
Resof Total Tablet is a fixed-dose combination tablet containing Sofosbuvir (400mg) and Velpatasvir (100mg), used for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
| Manufacturer | Dr. Reddy’s Laboratories Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Rompag 25mg/50mg Tablet contains Eltrombopag, a thrombopoietin receptor agonist used to treat low platelet counts in patients with conditions like chronic immune thrombocytopenia (ITP), aplastic anemia, or hepatitis C-associated thrombocytopenia.
| Composition | Eltrombopag |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 7 Tablets in 1 Strip |
| Prescribed For | Chronic Immune Thrombocytopenia |
| Expiry | December 2027 |
Sofocure V tablet is a combination antiviral medicine containing Sofosbuvir 400mg and Velpatasvir 100mg. It is used for the treatment of chronic Hepatitis C virus (HCV) infection across all six genotypes.
| Composition | Sofosbuvir 400mg + Velpatasvir 100mg |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Hepatitis C |
| Expiry | December 2027 |
Sofokast Plus Tablet is an oral antiviral medication combining Sofosbuvir 400 mg and Daclatasvir 60 mg, used in treating chronic hepatitis C virus (HCV) infection.
| Composition | Sofosbuvir 400 mg and Daclatasvir 60 mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | HCV Infection |
| Expiry | December 2027 |
Sorafekast 200mg contains Sorafenib, a targeted cancer therapy used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), kidney cancer (Renal Cell Carcinoma), and certain types of thyroid cancer.
| Composition | Sorafenib (200mg) |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 120 Tablets in 1 Bottle |
| Prescribed For | Liver Cancer, Kidney Cancer and Thyroid Cancer |
| Expiry | December 2027 |
Spegra Tablet is a once-daily antiretroviral medication used to treat HIV-1 infection in adults. It combines three powerful ingredients Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) to effectively suppress the HIV virus, reduce its ability to multiply, and strengthen the immune system.
| Composition | Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Spnib 50mg/100mg contains dasatinib, a tyrosine kinase inhibitor used to treat certain types of blood cancers, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+).
| Composition | Dasatinib |
| Manufacturer | Zydus Cadila |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Sprycel 50mg contains Dasatinib, a targeted cancer therapy used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | BMS India Pvt Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Stivarga 40 mg Tablet contains Regorafenib, an oral targeted therapy used to treat certain types of cancers such as metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Bayer |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Metastatic Colorectal Cancer, GIST, and Hepatocellular Carcinoma |
| Expiry | December 2027 |
Sunicine 50mg Capsule contains Sunitinib, a targeted cancer therapy used to treat various cancers, including advanced kidney cancer (Renal Cell Carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Arechar Healthcare |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer and GIST, pNET |
| Expiry | December 2027 |
Sunisam 50 mg Capsules contains Sunitinib, an oral targeted therapy used in the treatment of various cancers, including advanced kidney cancer (Renal Cell Carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Samarth Life Sciences Pvt Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Kidney Cancer, GIST and pNET |
| Expiry | December 2027 |
Sunitax 25 mg capsule is a targeted cancer therapy containing Sunitinib Malate, used primarily to treat certain types of advanced cancers such as renal cell carcinoma (kidney cancer) and gastrointestinal stromal tumors (GIST).
| Composition | Sunitinib |
| Manufacturer | Aureate Healthcare Pvt Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Kidney Cancer and Gastrointestinal Stromal Tumors |
| Expiry | December 2027 |
Sunixar 25/50mg Capsule is an oral cancer medication containing Sunitinib Malate, used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 capsules in 1 Strip |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutekast 50 mg Capsule is an oral cancer medication containing Sunitinib Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutib 50mg Capsule contains Sunitinib Malate, a targeted cancer treatment used for managing advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 28 Capsules in 1 Box |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutinat 50mg Capsule is an oral anti-cancer medication that contains Sunitinib Malate, a targeted therapy used to treat certain advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutykine 50 mg Capsule is an oral targeted therapy that contains Sunitinib Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Anticancer |
| Expiry | December 2027 |
Svitinib 50mg Capsule is an oral anti-cancer medication containing Sunitinib Malate, a targeted therapy used in the treatment of renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Packing | 30 Capsules |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Tafero EM Tablet is a combination of Tenofovir Alafenamide 25 mg and Emtricitabine 200 mg, used for the treatment and prevention of HIV-1 infection.
| Composition | Tenofovir Alafenamide 25 mg + Emtricitabine (200 mg) |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tenof EM Tablet contains two antiretroviral medicines: emtricitabine (200 mg) and tenofovir disoproxil fumarate (300 mg), and it is used to treat and prevent HIV-1 infection in adults and teenagers.
| Composition | Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg) |
| Manufacturer | Hetero Drugs Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tenvir-EM Tablet is a combination of Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg), used in the treatment and prevention of HIV-1 infection.
| Composition | Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg) |
| Manufacturer | Cipla Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tipanat 20 is an oral chemotherapy medication used in the treatment of advanced or metastatic colorectal cancer and gastric (stomach) cancer. It contains a combination of Trifluridine (antineoplastic agent) and Tipiracil (a thymidine phosphorylase inhibitor).
| Composition | Tipiracil (8.19mg) + Trifluridine (20mg) |
| Manufacturer | Natco Pharma Ltd |
| Packing | 20 Tablets in 1 Bottle |
| Prescribed For | Stomach Cancer |
| Expiry | December 2027 |
Tofajak 5 mg Tablet contains Tofacitinib, a Janus kinase (JAK) inhibitor used primarily to treat autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
| Composition | Tofacitinib |
| Manufacturer | Cipla Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Diarrhoea Headache High Blood Pressure |
| Expiry | December 2027 |
Tudobest 300 mg Tablet contains Tenofovir Disoproxil Fumarate, an antiretroviral medication used in the treatment of HIV-1 infection and chronic hepatitis B virus (HBV) infection.
| Composition | Tenofovir Disoproxil Fumarate |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 infection |
| Expiry | December 2027 |
Tunib 50mg Capsule contains Sunitinib Malate, a targeted cancer therapy used to treat advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and certain types of pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Mankind Pharmaceuticals Limited |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer |
| Expiry | December 2027 |
Twinaqt Tablet is a combination antiretroviral medication containing Dolutegravir (50 mg) and Lamivudine (300 mg). It is used for the treatment of HIV-1 infection in adults and adolescents.
| Composition | Dolutegravir 50mg + Lamivudine 300mg |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in a Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Velakast Tablet is a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Tablets in a Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Velasof 400 mg/100 mg Tablet is a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), used to treat chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
| Manufacturer | Hetero Healthcare Ltd |
| Packing | 28 Tablets in a Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Viropil Tablet is a fixed-dose antiretroviral combination containing Dolutegravir (50 mg), Lamivudine (300 mg), and Tenofovir Disoproxil Fumarate (300 mg). It is used in the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg.
| Composition | Dolutegravir (50mg) + Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Xbira 250 mg and 500 mg tablets contain Abiraterone Acetate, a hormonal therapy used in the treatment of prostate cancer, particularly metastatic castration-resistant prostate cancer (mCRPC).
| Composition | Abiraterone Acetate |
| Manufacturer | Cipla Ltd |
| Packing | 120 Tablets in a Bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Xylutide 40mg Capsule contains Enzalutamide, a medication used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer.
| Composition | Enzalutamide |
| Manufacturer | Cipla Ltd |
| Packing | 4 Capsules in 1 Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Zecyte 250mg Tablet contains Abiraterone Acetate, a hormonal therapy used to treat metastatic castration-resistant prostate cancer (mCRPC).
| Composition | Abiraterone Acetate |
| Manufacturer | Cipla Ltd |
| Packing | 120 Tablets in a Bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Zoldonat 4 mg Injection contains zoledronic acid and is used to treat high blood calcium levels caused by cancer, prevent bone complications in cancers like breast or prostate cancer, and manage conditions such as osteoporosis and Paget’s disease.
| Composition | Zoledronic Acid |
| Manufacturer | Natco Pharma Ltd |
| Packing | 1 Injection in 1 vial |
| Prescribed For | Osteoporosis |
| Expiry | December 2027 |
Hepcinat 400 mg contains Sofosbuvir and is used to treat chronic Hepatitis C virus (HCV) infection in adults and children (aged 3 and above).
| Composition | Sofosbuvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets in 1 Strip |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Glenza 40 mg capsule has enzalutamide in it and is used to treat advanced prostate cancer, particularly in men whose cancer does not respond to hormone therapy, regardless of whether it has spread to other parts of the body.
| Composition | Enzalutamide |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 14 Capsules in a Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Glenvas 10mg Capsule contains Lenvatinib, an oral targeted therapy used to treat certain types of advanced cancers, including thyroid cancer, liver cancer, kidney cancer, and endometrial cancer.
| Composition | Lenvatinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid, Liver & Kidney Cancer |
| Expiry | December 2027 |
Geftinat 250mg Tablet contains Gefitinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC), especially in patients with EGFR gene mutations.
| Composition | Gefitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 Strip |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Forxiga 10 mg tablet contains Dapagliflozin, an oral medication used to manage type 2 diabetes, heart failure, and chronic kidney disease (CKD).
| Composition | Dapagliflozin |
| Manufacturer | AstraZeneca |
| Packing | 14 Tablets in 1 Strip |
| Prescribed For | Anti Diabetic |
| Expiry | December 2027 |
Evermil 5mg tablet contains Everolimus, an anti-cancer medicine used to treat certain types of advanced kidney cancer, breast cancer, neuroendocrine tumors, and tuberous sclerosis-related conditions.
| Composition | Everolimus |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Neuroendocrine Tumors, Kidney & Breast Cancer |
| Expiry | December 2027 |
Enzyl 40mg capsule is an oral anti-cancer medication containing Enzalutamide, primarily used to treat advanced prostate cancer, especially castration-resistant prostate cancer (CRPC).
| Composition | Enzalutamide |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 28 Capsules in a Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Enzana 40mg Capsule contains Enzalutamide, a medication used to treat prostate cancer that has spread or is resistant to standard hormone therapy.
| Composition | Enzalutamide |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Enzamide 40 mg contains enzalutamide, a nonsteroidal androgen receptor inhibitor prescribed primarily for castration-resistant prostate cancer (CRPC)—both metastatic (spread beyond the prostate) and non-metastatic forms.
| Composition | Enzalutamide |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 28 Tablets in 1 Strip |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Efavir 600 Tablet contains Efavirenz 600 mg, an antiretroviral medicine used in the treatment of HIV-1 infection. It works by blocking the reverse transcriptase enzyme, which the HIV virus needs to multiply.
| Composition | Efavirenz 600 mg |
| Manufacturer | Cipla Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | HIV infection |
| Expiry | December 2027 |
Dyronib 50 mg Tablet is an oral anti-cancer medication containing Dasatinib, a tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Daslemia 70 mg is an oral prescription medication that contains dasatinib, a targeted therapy classified as a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Ph+ acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Dasatrue 70 mg tablet contains dasatinib and is used to treat certain types of blood cancer, especially chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It helps stop the growth of abnormal white blood cells.
| Composition | Dasatinib |
| Manufacturer | Cipla Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Dasashil 70mg is a prescription cancer medicine that contains Dasatinib, a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Dasapan 70mg is a prescription medicine that contains Dasatinib, a potent tyrosine kinase inhibitor (TKI) used in the treatment of specific blood cancers. It is primarily prescribed to patients with Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Mankind Pharma Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Dasamyl 100 mg contains dasatinib, and it is a targeted therapy medication used in the treatment of certain types of blood cancer, specifically Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Composition | Dasatinib |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
